Literature DB >> 35962282

Antagonistic activity of selenium-enriched Bifidobacterium breve against Clostridioides difficile.

Wen Rui1, Chenyu Gu1, Huiru Zhang1, Xinwei Liao1, Xinyu Zhao1, Yujia Xu1, Jingpeng Yang2.   

Abstract

Probiotics have the potential to be used in the prevention of Clostridioides difficile infection (CDI). In this study, selenium (Se)-enriched Bifidobacterium breve YH68-Se was obtained under optimal culture conditions with single-factor and response surface optimization. The overall environmental resistance of YH68-Se was superior to that of the parental strain YH68, mainly reflected in the substantial improvement of antioxidant activity and gastrointestinal tolerance. YH68-Se dramatically inhibited C. difficile growth, spore, biofilm, toxin production, and virulence gene expression, rapidly disrupted C. difficile cell membrane permeability and integrity, and altered the membrane proton motive force (PMF), induced a large outflow of intracellular substances and eventually caused bacterial death. The main factor inducing this process originated from the lactic acid (LD) in YH68-Se. In addition, the LD production of YH68 increased with increasing selenite concentration and was accompanied by enhanced activities of thioredoxin reductase (TrxR), glutathione peroxidase (GSH-Px), and increased concentration of autoinducer-2 (AI-2), which may be the crucial factors contributing to the outstanding probiotic properties of YH68-Se and their potent antagonism of C. difficile. KEY POINTS: • Compared with the parental strain B. breve YH68, the environmental resistance of YH68-Se was improved. • YH68-Se was able to produce more lactic acid, which suppressed the important physiological activities of C. difficile and rapidly disrupted their cell membrane structures. • Sodium selenite in the suitable concentration range gradually increases the yield of lactic acid and phenylacetic acid, increased the concentration of autoinducer-2, and enhanced the activities of antioxidant enzymes TrxR and GSH-Px in YH68.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Autoinducer-2; Cell membrane permeability; Clostridioides difficile; Lactic acid; Se-enriched Bifidobacterium breve; Sodium selenite

Mesh:

Substances:

Year:  2022        PMID: 35962282     DOI: 10.1007/s00253-022-12124-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  12 in total

Review 1.  Bacteriocin production by Bifidobacterium spp. A review.

Authors:  Fabio Andres Castillo Martinez; Eduardo Marcos Balciunas; Attilio Converti; Paul D Cotter; Ricardo Pinheiro de Souza Oliveira
Journal:  Biotechnol Adv       Date:  2013-02-04       Impact factor: 14.227

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

3.  Cellular and mitochondrial determination of low molecular mass organic acids by LC-MS/MS.

Authors:  Jessica Fiori; Elisa Amadesi; Flaminia Fanelli; Concetta Valentina Tropeano; Michela Rugolo; Roberto Gotti
Journal:  J Pharm Biomed Anal       Date:  2017-11-29       Impact factor: 3.935

Review 4.  A review of Clostridioides [Clostridium] difficile occurrence through the food chain.

Authors:  Carmen Candel-Pérez; Gaspar Ros-Berruezo; Carmen Martínez-Graciá
Journal:  Food Microbiol       Date:  2018-08-22       Impact factor: 5.516

5.  Protective Effects of Selenium Nanoparticle-Enriched Lactococcus lactis NZ9000 against Enterotoxigenic Escherichia coli K88-Induced Intestinal Barrier Damage in Mice.

Authors:  Yue Chen; Lei Qiao; Xiaofan Song; Li Ma; Xina Dou; Chunlan Xu
Journal:  Appl Environ Microbiol       Date:  2021-09-15       Impact factor: 4.792

6.  MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data.

Authors:  Jasmine Chong; Jianguo Xia
Journal:  Bioinformatics       Date:  2018-12-15       Impact factor: 6.937

7.  Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile.

Authors:  Jingpeng Yang; Hong Yang
Journal:  Front Cell Infect Microbiol       Date:  2019-08-07       Impact factor: 5.293

Review 8.  The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Authors:  Seppo Salminen; Maria Carmen Collado; Akihito Endo; Colin Hill; Sarah Lebeer; Eamonn M M Quigley; Mary Ellen Sanders; Raanan Shamir; Jonathan R Swann; Hania Szajewska; Gabriel Vinderola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-04       Impact factor: 73.082

9.  Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics.

Authors:  Joshua Z Goldenberg; Dominik Mertz; Bradley C Johnston
Journal:  JAMA       Date:  2018-08-07       Impact factor: 56.272

10.  Anti-Biofilm Activity of a Long-Chain Fatty Aldehyde from Antarctic Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis Biofilm.

Authors:  Angela Casillo; Rosanna Papa; Annarita Ricciardelli; Filomena Sannino; Marcello Ziaco; Marco Tilotta; Laura Selan; Gennaro Marino; Maria M Corsaro; Maria L Tutino; Marco Artini; Ermenegilda Parrilli
Journal:  Front Cell Infect Microbiol       Date:  2017-02-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.